SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001571049-16-013439
Filing Date
2016-03-29
Accepted
2016-03-29 16:59:57
Documents
88
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K t1600767-10k.htm 10-K 1249078
2 EXHIBIT 23.1 t1600767_ex23-1.htm EX-23.1 1949
3 EXXHIBIT 31.1 t1600767_ex31-1.htm EX-31.1 9374
4 EXHIBIT 31.2 t1600767_ex31-2.htm EX-31.2 9512
5 EXHIBIT 32.1 t1600767_ex32-1.htm EX-32.1 4001
6 EXHIBIT 32.2 t1600767_ex32-2.htm EX-32.2 3975
  Complete submission text file 0001571049-16-013439.txt   5967336

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cycc-20151231.xml EX-101.INS 1059885
8 XBRL SCHEMA FILE cycc-20151231.xsd EX-101.SCH 59603
9 XBRL CALCULATION FILE cycc-20151231_cal.xml EX-101.CAL 63049
10 XBRL DEFINITION FILE cycc-20151231_def.xml EX-101.DEF 213031
11 XBRL LABEL FILE cycc-20151231_lab.xml EX-101.LAB 546706
12 XBRL PRESENTATION FILE cycc-20151231_pre.xml EX-101.PRE 384614
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 161535903
SIC: 2834 Pharmaceutical Preparations